表紙
市場調查報告書

DTC (Direct-to-Consumer) 遺傳基因檢驗的全球市場:2019年∼2023年

Direct-to-consumer Genetic Testing Market by Distribution Channel, Service, and Geography - Global Forecast and Analysis 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 909622
出版日期 內容資訊 英文 123 Pages
訂單完成後即時交付
價格
Back to Top
DTC (Direct-to-Consumer) 遺傳基因檢驗的全球市場:2019年∼2023年 Direct-to-consumer Genetic Testing Market by Distribution Channel, Service, and Geography - Global Forecast and Analysis 2019-2023
出版日期: 2019年08月23日內容資訊: 英文 123 Pages
簡介

全球DTC (Direct-to-Consumer) 遺傳基因檢驗市場,早期疾病診斷的DTC遺傳基因檢驗的採用增加,可支配所得的增加,DTC遺傳基因檢測套組的法規當局的認證增加等成為成長促進因素,在預測期間內預計將以16%以上的年複合成長率擴大。但,對分析及臨床性有效性的疑念,特定的償付政策,及個人資料的安全性和隱私相關疑慮等的要素,可能妨礙在預測期間內DTC 遺傳基因檢驗產業的成長。

本報告提供全球DTC (Direct-to-Consumer) 遺傳基因檢驗市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各流通管道

  • 市場區隔:各流通管道
  • 各流通管道比較:市場規模及預測(2018年∼2023年)
  • 直銷
  • 零售
  • 市場機會:各流通管道

第7章 客戶形勢

第8章 市場區隔:各類服務

  • 市場區隔:各類服務

第9章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 下一代的遺傳基因序列測定的進步
  • 服務的降低成本
  • 線上服務平台採用的增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • 23andMe Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31918

About this market

Technavio's direct-to-consumer genetic testing market analysis considers sales from both direct sales and retail sales. Our analysis also considers the sales of direct-to-consumer genetic testing in Asia, Europe, North America, and ROW. In 2018, the direct sales segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as a reduction in additional costs involved in distribution and logistics will play a significant role in the direct sales segment to maintain its market position. Also, our global direct-to-consumer genetic testing market report looks at factors such as growing adoption of direct-to-consumer genetic testing in early disease diagnosis, rising disposable income, and increasing regulatory approvals of direct-to-consumer genetic testing kits. However, doubts over-analytical and clinical validity, limited reimbursement policies, and concerns over safety and privacy of personal data may hamper the growth of the direct-to-consumer genetic testing industry over the forecast period.

Overview

Growing adoption of direct-to-consumer genetic testing in early disease diagnosis

The adoption of direct-to-consumer genetic testing has increased, especially among people with a family history of certain diseases with a greater chance of their genetic transmission to their progeny. The increasing number of people with Alzheimer, cancer, and Parkinson's disease has fueled the demand for these tests. Direct-to-consumer genetic testing kit helps in the early diagnosis of diseases and help approach physicians for further monitoring and prevention. This will lead to the expansion of the global direct-to-consumer genetic testing market at a CAGR of over 16% during the forecast period.

Growing adoption of online service platforms

The increase in the adoption of digital trends in the healthcare industry has enabled vendors to have the edge over their competitors by offering better healthcare services. Online ordering facilities has increased the propensity of the consumers to avail more direct-to-consumer genetic tests. This leads the companies to provide attractive discounts to promote sales through online platforms. The availability of a digital database of consumers helps companies to analyze the performance of their products and improve through constant development and upgrades. This adoption of online service platforms is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global direct-to-consumer genetic testing market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global direct-to-consumer genetic testing market is moderately fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading direct-to-consumer genetic testing manufacturers, that include 23andMe Inc., Invitae Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., Quest Diagnostics Inc.

Also, the direct-to-consumer genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL

  • Market segmentation by distribution channel
  • Comparison by distribution channel
  • Direct sales - Market size and forecast 2018-2023
  • Retail sales - Market size and forecast 2018-2023
  • Market opportunity by distribution channel

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY SERVICE

  • Market segmentation by service

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Advances in next-generation genetic sequencing
  • Reduction in the cost of services
  • Growing adoption of online service platforms

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • 23andMe Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Distribution channel - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by distribution channel
  • Exhibit 20: Direct sales - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Direct sales - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Retail sales - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Retail sales - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by distribution channel
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global direct-to-consumer genetic testing market: Segmentation by service 2018 (%)
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: 23 andMe Inc. - Vendor overview
  • Exhibit 46: 23 andMe Inc. - Business segments
  • Exhibit 47: 23 andMe Inc. - Organizational developments
  • Exhibit 48: 23 andMe Inc. - Key offerings
  • Exhibit 49: Invitae Corp. - Vendor overview
  • Exhibit 50: Invitae Corp. - Business segments
  • Exhibit 51: Invitae Corp. - Organizational developments
  • Exhibit 52: Invitae Corp. - Geographic focus
  • Exhibit 53: Invitae Corp. - Key offerings
  • Exhibit 54: Laboratory Corp. of America Holdings - Vendor overview
  • Exhibit 55: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 56: Laboratory Corp. of America Holdings - Organizational developments
  • Exhibit 57: Laboratory Corp. of America Holdings - Geographic focus
  • Exhibit 58: Laboratory Corp. of America Holdings - Segment focus
  • Exhibit 59: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 60: Myriad Genetics Inc. - Vendor overview
  • Exhibit 61: Myriad Genetics Inc. - Business segments
  • Exhibit 62: Myriad Genetics Inc. - Organizational developments
  • Exhibit 63: Myriad Genetics Inc. - Segment focus
  • Exhibit 64: Myriad Genetics Inc. - Key offerings
  • Exhibit 65: Quest Diagnostics Inc. - Vendor overview
  • Exhibit 66: Quest Diagnostics Inc. - Business segments
  • Exhibit 67: Quest Diagnostics Inc. - Organizational developments
  • Exhibit 68: Quest Diagnostics Inc. - Geographic focus
  • Exhibit 69: Quest Diagnostics Inc. - Segment focus
  • Exhibit 70: Quest Diagnostics Inc. - Key offerings
  • Exhibit 71: Validation techniques employed for market sizing
  • Exhibit 72: Definition of market positioning of vendors
Back to Top